期刊
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
卷 47, 期 4-5, 页码 413-423出版社
OXFORD UNIV PRESS
DOI: 10.1007/s10295-020-02277-5
关键词
Streptomyces; CRISPR-Cas9; Theophylline riboswitch; Genome editing; Glycerol
资金
- European Union's Horizon 2020 Research and Innovation Programme [720793 TOPCAPI]
- H2020 TOPCAPI
- US National Institutes of Health (NIH) [AI144967]
- EPSRC [EP/S01778X/1] Funding Source: UKRI
CRISPR-Cas9 has proven as a very powerful gene editing tool for Actinomyces, allowing scarless and precise genome editing in selected strains of these biotechnologically relevant microorganisms. However, its general application in actinomycetes has been limited due to its inefficacy when applying the system in an untested strain. Here, we provide evidence of how Cas9 levels are toxic for the model actinomycetes Streptomyces coelicolor M145 and Streptomyces lividans TK24, which show delayed or absence of growth. We overcame this toxicity by lowering Cas9 levels and have generated a set of plasmids in which Cas9 expression is either controlled by theophylline-inducible or constitutive promoters. We validated the targeting of these CRISPR-Cas9 system using the glycerol uptake operon and the actinorhodin biosynthesis gene cluster. Our results highlight the importance of adjusting Cas9 expression levels specifically in strains to gain optimum and efficient gene editing in Actinomyces.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据